Patent · US Active

Anti-TIGIT antigen-binding proteins and methods of use thereof

US9713641B2 · kind B2 · utility

26Cited by

3References

20Claims

0Family size

Assignee

Potenza Therapeutics, Inc. · US

Inventors

Daniel Hicklin · Montclair, US
William Winston · Marlborough, US
Cynthia S. Dugan · Belmont, US
Nels P. Nielson · Cambridge, US

Key dates

Filing date	Feb 13, 2017
Grant date	Jul 25, 2017
Priority date	—
Expiry date	Feb 13, 2037

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are antigen-binding proteins (ABPs) that selectively bind to TIGIT and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.